EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

5.74
Delayed Data
As of 4:00pm ET
 -0.25 / -4.17%
Today’s Change
3.78
Today|||52-Week Range
16.90
+1.23%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close5.99
Today’s open5.99
Day’s range5.68 - 6.00
Volume113,920
Average volume (3 months)221,733
Market cap$140.9M
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)+59.46%
Earnings growth (this year)+76.60%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.97%
P/E ratioNM
Price/Sales8,705.73
Price/Book2.39

Competitors

 Today’s
change
Today’s
% change
--United Gene High-Tec...-0.01-8.33%
FBIOFortress Biotech Inc-0.06-1.99%
PVCTProvectus Biopharmac...+0.01+0.66%
SYNSynthetic Biologics ...-0.05-2.65%
Data as of 4:00pm ET, 05/28/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$4.0K
Annual profit (last year)-$41.8M
Net profit margin-1,046,100.00%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers